Skip to main content
NCBI home page
The Journal of Cell Biology logoLink to The Journal of Cell Biology
. 1989 Jan 1;108(1):177–182. doi: 10.1083/jcb.108.1.177

An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity

PMCID: PMC2115360  PMID: 2492023

Abstract

We have recently described the purification and characterization of an insulin-degrading enzyme (IDE) from Drosophila melanogaster that can cleave porcine insulin, is highly conserved through evolution and is developmentally regulated. We now report that the IDE is, in fact, an insulin EGF-binding protein (dp100) that we had isolated previously from Drosophila using an antihuman EGF receptor antiserum. This conclusion is based upon the following evidence. (a) dp100, identified by its ability to cross-link to labeled insulin, EGF, and transforming growth factor-alpha (TGF-alpha), and to be immunoprecipitated by anti- EGF receptor antisera, copurifies with the IDE activity. Thus, the purified IDE can be affinity labeled with either 125I-insulin, 125I- EGF, or 125I-TGF-alpha, and this labeling is specifically inhibited with unlabeled insulin, EGF, and the insulin B chain. (b) The antiserum to the human EGF receptor, which recognizes dp100, is able to specifically immunoprecipitate the insulin-degrading activity. (c) The purified IDE preparation contains a single protein of 110 kD which is recognized by both the anti-EGF receptor antiserum and anti-Drosophila IDE antiserum. (d) Polyclonal antiserum to the purified IDE, which specifically recognized only the 110-kD band in Drosophila Kc cells, immunoprecipitates dp100 cross-linked to 125I-TGF-alpha and dp100 cross- linked to 125I-insulin from the purified IDE preparation. (e) EGF, which competes with insulin for binding to dp100, also inhibits the degradation of insulin by the purified IDE. These results raise the possibility that a functional interaction between the insulin and EGF growth factor families can occur which is mediated by the insulin- degrading enzyme.

Full Text

The Full Text of this article is available as a PDF (1.4 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Decker S. Purification of denatured epidermal growth factor-receptor from A431 human epidermoid carcinoma cells. Arch Biochem Biophys. 1984 Feb 1;228(2):621–626. doi: 10.1016/0003-9861(84)90031-6. [DOI] [PubMed] [Google Scholar]
  2. Duckworth W. C., Heinemann M. A., Kitabchi A. E. Purification of insulin-specific protease by affinity chromatography. Proc Natl Acad Sci U S A. 1972 Dec;69(12):3698–3702. doi: 10.1073/pnas.69.12.3698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fernandez-Almonacid R., Rosen O. M. Structure and ligand specificity of the Drosophila melanogaster insulin receptor. Mol Cell Biol. 1987 Aug;7(8):2718–2727. doi: 10.1128/mcb.7.8.2718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Friedman B., Frackelton A. R., Jr, Ross A. H., Connors J. M., Fujiki H., Sugimura T., Rosner M. R. Tumor promoters block tyrosine-specific phosphorylation of the epidermal growth factor receptor. Proc Natl Acad Sci U S A. 1984 May;81(10):3034–3038. doi: 10.1073/pnas.81.10.3034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garcia J. V., Fenton B. W., Rosner M. R. Isolation and characterization of an insulin-degrading enzyme from Drosophila melanogaster. Biochemistry. 1988 Jun 14;27(12):4237–4244. doi: 10.1021/bi00412a006. [DOI] [PubMed] [Google Scholar]
  6. Garcia J. V., Stoppelli M. P., Thompson K. L., Decker S. J., Rosner M. R. Characterization of a Drosophila protein that binds both epidermal growth factor and insulin-related growth factors. J Cell Biol. 1987 Jul;105(1):449–456. doi: 10.1083/jcb.105.1.449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Krupp M. N., Lane M. D. Evidence for different pathways for the degradation of insulin and insulin receptor in the chick liver cell. J Biol Chem. 1982 Feb 10;257(3):1372–1377. [PubMed] [Google Scholar]
  8. Marshall S. Degradative processing of internalized insulin in isolated adipocytes. J Biol Chem. 1985 Nov 5;260(25):13517–13523. [PubMed] [Google Scholar]
  9. Marshall S. Dual pathways for the intracellular processing of insulin. Relationship between retroendocytosis of intact hormone and the recycling of insulin receptors. J Biol Chem. 1985 Nov 5;260(25):13524–13531. [PubMed] [Google Scholar]
  10. Meneses P., De Los Angeles Ortíz M. A protein extract from Drosophila melanogaster with insulin-like activity. Comp Biochem Physiol A Comp Physiol. 1975 Jun 1;51(2):483–485. doi: 10.1016/0300-9629(75)90398-9. [DOI] [PubMed] [Google Scholar]
  11. O'Farrell P. H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975 May 25;250(10):4007–4021. [PMC free article] [PubMed] [Google Scholar]
  12. Petruzzelli L., Herrera R., Arenas-Garcia R., Fernandez R., Birnbaum M. J., Rosen O. M. Isolation of a Drosophila genomic sequence homologous to the kinase domain of the human insulin receptor and detection of the phosphorylated Drosophila receptor with an anti-peptide antibody. Proc Natl Acad Sci U S A. 1986 Jul;83(13):4710–4714. doi: 10.1073/pnas.83.13.4710. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Petruzzelli L., Herrera R., Garcia-Arenas R., Rosen O. M. Acquisition of insulin-dependent protein tyrosine kinase activity during Drosophila embryogenesis. J Biol Chem. 1985 Dec 25;260(30):16072–16075. [PubMed] [Google Scholar]
  14. Roth R. A., Mesirow M. L., Cassell D. J., Yokono K., Baba S. Characterization of an insulin degrading enzyme from cultured human lymphocytes. Diabetes Res Clin Pract. 1985 Mar;1(1):31–39. doi: 10.1016/s0168-8227(85)80026-7. [DOI] [PubMed] [Google Scholar]
  15. Schejter E. D., Segal D., Glazer L., Shilo B. Z. Alternative 5' exons and tissue-specific expression of the Drosophila EGF receptor homolog transcripts. Cell. 1986 Sep 26;46(7):1091–1101. doi: 10.1016/0092-8674(86)90709-9. [DOI] [PubMed] [Google Scholar]
  16. Shii K., Roth R. A. Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. Proc Natl Acad Sci U S A. 1986 Jun;83(12):4147–4151. doi: 10.1073/pnas.83.12.4147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Shii K., Yokono K., Baba S., Roth R. A. Purification and characterization of insulin-degrading enzyme from human erythrocytes. Diabetes. 1986 Jun;35(6):675–683. doi: 10.2337/diab.35.6.675. [DOI] [PubMed] [Google Scholar]
  18. Stoppelli M. P., Garcia J. V., Decker S. J., Rosner M. R. Developmental regulation of an insulin-degrading enzyme from Drosophila melanogaster. Proc Natl Acad Sci U S A. 1988 May;85(10):3469–3473. doi: 10.1073/pnas.85.10.3469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Thompson K. L., Decker S. J., Rosner M. R. Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin. Proc Natl Acad Sci U S A. 1985 Dec;82(24):8443–8447. doi: 10.1073/pnas.82.24.8443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Wharton K. A., Johansen K. M., Xu T., Artavanis-Tsakonas S. Nucleotide sequence from the neurogenic locus notch implies a gene product that shares homology with proteins containing EGF-like repeats. Cell. 1985 Dec;43(3 Pt 2):567–581. doi: 10.1016/0092-8674(85)90229-6. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Cell Biology are provided here courtesy of The Rockefeller University Press

RESOURCES